Literature DB >> 15214048

Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway.

Amnon Altman1, Sandra Kaminski, Valere Busuttil, Nathalie Droin, Junru Hu, Yuri Tadevosyan, Robert A Hipskind, Martin Villalba.   

Abstract

PKCtheta plays an essential role in activation of mature T cells. Here, we report that the TCR/CD28-induced tyrosine phosphorylation and activation of PLCgamma1 was significantly impaired in PKCtheta (-/-) primary, restimulated T cells. Consistent with this finding, receptor-induced Ca(2+) mobilization, NF-AT DNA-binding activity and the membrane translocation of PKCalpha, a PLCgamma1-dependent conventional PKC, were also markedly reduced in the same cells. Moreover, a dominant-negative PLCgamma1 mutant blocked the PKCtheta-induced activation of an AP-1 reporter gene in Jurkat and primary cells. Regulation of PLCgamma1 signaling by PKCtheta required the tyrosine kinase Tec since a dominant-negative Tec mutant blocked PKCtheta-induced AP-1 (but not NF-kappaB) activation. In addition, wild-type Tec, but not Itk or Rlk, potently activated AP-1. Furthermore, Tec was found to constitutively associate with PKCtheta, an interaction that like AP-1 activation required the pleckstrin-homology domain of Tec. These findings define a novel PKCtheta-initiated pathway that regulates Ca(2+) signaling and AP-1 activation via Tec and PLCgamma1. Moreover, they identify Tec as a key point downstream of PKCtheta, where TCR- and PKCtheta-induced signaling pathways, leading to AP-1 versus NF-kappaB activation, diverge in T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214048     DOI: 10.1002/eji.200324625

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.

Authors:  Jian Ma; Yan Ding; Xianfeng Fang; Ruiqing Wang; Zuoming Sun
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity.

Authors:  Natascha Hermann-Kleiter; Thomas Gruber; Christina Lutz-Nicoladoni; Nikolaus Thuille; Friedrich Fresser; Verena Labi; Natalia Schiefermeier; Marei Warnecke; Lukas Huber; Andreas Villunger; Gregor Eichele; Sandra Kaminski; Gottfried Baier
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

4.  A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation.

Authors:  Vinh Nguyen; Lulu Cao; Jonathan T Lin; Norris Hung; Anna Ritz; Kebing Yu; Radu Jianu; Samuel P Ulin; Benjamin J Raphael; David H Laidlaw; Laurent Brossay; Arthur R Salomon
Journal:  Mol Cell Proteomics       Date:  2009-07-14       Impact factor: 5.911

Review 5.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

6.  Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta.

Authors:  Sergey A Trushin; Gary D Bren; Susana Asin; Kevin N Pennington; Carlos V Paya; Andrew D Badley
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Authors:  Natalia R Comet; Juan Ignacio Aguiló; Moeez G Rathoré; Elena Catalán; Johan Garaude; Gilles Uzé; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

8.  A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.

Authors:  Santhakumar Manicassamy; Dengping Yin; Zheng Zhang; Luciana L Molinero; Marisa-Luisa Alegre; Zuoming Sun
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion.

Authors:  Ilaria Tassi; Marina Cella; Rachel Presti; Angela Colucci; Susan Gilfillan; Dan R Littman; Marco Colonna
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

10.  Differential requirement of PKC-theta in the development and function of natural regulatory T cells.

Authors:  Sonal Gupta; Santhakumar Manicassamy; Chenthamarakshan Vasu; Anvita Kumar; Weirong Shang; Zuoming Sun
Journal:  Mol Immunol       Date:  2008-10-08       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.